Latest News
Kimberly-Clark Corporation
- Kimberly-Clark Offers Bonds to Help Fund Tylenol Maker Takeover
- Kimberly-Clark readies a five-part bond sale to help pay for Tylenol maker Kenvue
- Kimberly-Clark beats Q3 earnings and reaffirms outlook: Can KMB sustain recent gains?
- Kimberly-Clark posts preliminary results above estimates, China clears formamide claims
- Kimberly-Clark maintains 2026 outlook despite China disruptions By Investing.com
- Cramer's Mad Dash: Kimberly-Clark Corporation
- How Kimberly-Clark Navigates Slower Growth Across Consumer Categories?
- EU okays Kimberly-Clark bid for Neutrogena-owner Kenvue
- Kimberly-Clark, Kenvue Win Conditional EU Approval for $40 Billion Tie-Up
- EU approves Kimberly-Clark's $40 billion Kenvue acquisition
- Kimberly-Clark/Kenvue set to win EU conditional clearance
- EU approves Kimberly-Clark's $40 billion Kenvue acquisition
Headlines from the last 30 days, linking to the original publishers. See all market news →